Skip to main content
Back
Watch Compare

Quoin Pharmaceuticals, Ltd.

Data quality: 83%
QNRX
Nasdaq Manufacturing Chemicals
$5.90
▲ $0.16 (2.79%)
Mkt Cap: 10.19 M
Price
$5.65
Mkt Cap
10.19 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -13.54 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-2364.66%
Below sector avg (-53.34%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio1.04
Interest CoverageN/A

Valuation

PE (TTM)
-0.64
Above sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.6 -1.5
P/B — 1.6
ROE % -2364.7 -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

3 analysts
Strong Buy
Current
$5.90
+402.8%
Target
$29.67
$14.00
$35.00
$40.00
Forecast
Forward P/E -1.87
Forward EPS -$3.15
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$3.15
-$3.15 – -$3.15
 0.0 1
FY2026 -$5.55
-$5.55 – -$5.55
 0.0 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$4.02 -$1.74 +56.7%
Q32025 -$1.92 -$6.70 -248.8%
Q22025 -$4.55 -$6.27 -37.9%
Q12025 -$4.20 -$6.50 -54.8%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -15.80 M
ROE -2364.66% ROA -206.11%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -13.54 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.04
Interest Coverage N/A Asset Turnover N/A
Working Capital 250,779 Tangible Book Value -1.62 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.64 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -132.88%
Market Cap 10.19 M Enterprise Value 8.36 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -7.51 OCF / Share -7.51
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 85.68%
SBC-Adj. FCF -14.72 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 0.0
Net Income -15.80 M -8.96 M -8.69 M -9.38 M -21.46 M
EPS (Diluted) — — — — -0.01
Gross Profit — — — — —
Operating Income — — — — —
EBITDA — — — — —
R&D Expenses 9.80 M 3.60 M 3.31 M 2.67 M 1.56 M
SG&A Expenses 6.49 M 5.93 M 6.07 M 6.58 M 4.50 M
D&A — — — — —
Interest Expense — — — — 1.09 M
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 20.39 M 15.71 M 12.17 M 14.46 M 9.36 M
Total Liabilities 7.27 M 6.50 M 6.51 M 7.05 M 8.70 M
Shareholders' Equity 13.12 M 9.20 M 5.66 M 7.41 M 657,032.0
Total Debt — — — — —
Cash & Equivalents 3.82 M 3.62 M 2.40 M 2.86 M 7.48 M
Current Assets 20.01 M 14.93 M 11.29 M 13.37 M 8.50 M
Current Liabilities 5.55 M 4.18 M 3.58 M 3.53 M —